About
Research
Patient Care
Education & Training
Community
Jan 11, 2023
Two faculty members awarded pilot funding for new projects to confront extremism through community, thriving and wellness
In recognition of their evidence-based research strategies to enhance best practices for community engagement and foster improvements in the aftermath of COVID-19, the UCI Office of Inclusive Excellence has awarded pilot funding to Sora Park Tanjasiri, DrPH, a professor of epidemiology and biostatistics and Alana LeBrón, PhD, an assistant professor of health, society, and behavior.
Nov 17, 2022
Five UCI faculty members make list of world’s top female scientists
Research.com’s first ranking of the top 1,000 female scientists in the world includes five UCI faculty members. Susan O'Brien, Associate Director for Clinical Science for the Chao Family Comprehensive Cancer Center has been included on this list. According to Research.com, the aim of this ranking is to inspire female scholars, women considering academic careers and decision-makers worldwide with examples of successful women in the scientific community. The rankings were created with the aim that they will help provide more opportunities, visibility and equal chances for women in science.
Aug 10, 2022 | UCI School of Medicine
New UCI-led research reveals the circadian clock influences cell growth, metabolism and tumor progression
UCI researchers have discovered how the circadian clock affects cell growth, metabolism, and genome stability, influencing tumor progression in the intestine.
New UCI-led study reveals computation-guided approach to suppressing cancer tumor growth
UCI and UCSD researchers have developed a method to identify molecules that restore mutated p53 tumor suppression, showing promise in both lab and animal models.
Jul 11, 2022
‘A window into the body’
The so-called “diagnostic fluid of the future,” saliva is loaded with DNA, enzymes, hormones, immune system markers and other substances that make it a minimally invasive alternative biospecimen to blood for a dizzying array of medical, nonmedical and even commercial uses. However, expertise is required to decipher biomarkers, many clinicians still do not collect saliva samples, and “spit science” research can literally be all over the map. That’s where UCI’s Institute for Interdisciplinary Salivary Bioscience Research comes in. Co-directed by Jenna Riis, assistant professor of psychological science, and Michael Hoyt, a clinical and health psychologist and associate professor of population health and disease prevention, the IISBR conducts salivary bioscience research and educates, trains and consults researchers, physicians, caregivers, veterinarians, psychologists and other professionals on collecting and analyzing spit samples.
Jun 24, 2022
Elizabeth Brem, MD, on Frontline Management of CLL
In the last few years, frontline management of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) has undergone a profound paradigm shift. First-line treatment with novel targeted therapies has become preferable to the use of chemoimmunotherapy regimens such as fludarabine, cyclophosphamide, and rituximab (FCR) -- the latter being largely reserved for patients younger than 65 with no comorbidities, and no 17p deletion or other TP53 mutations.
Jun 06, 2022
Melanoma researcher covers all the bases
Dr. Anand Ganesan probably won’t be hanging from a ceiling `a la Tom Cruise in Mission Impossible, but the UCI Health dermatologist and School of Medicine professor of dermatology and biological sciences does compare part of what he does to a plot device in the 1996 action thriller.
Apr 29, 2022
UCI researchers harness the power of mathematical modeling to understand the effectiveness of aspirin on colorectal cancer prevention
Aspirin can significantly reduce the incidence of colorectal cancer, and this protection can be the result of changed evolutionary processes of cells within patients, according to mathematical models produced by UCI researchers and partners. Results from the study were published in eLife Sciences.
Jan 26, 2022
UCI and CSU Fullerton partner to advance cancer health disparities research with a focus on diversity and inclusion
With a grant of more than $1.1 million from the National Cancer Institute (NCI), the UCI Chao Family Comprehensive Cancer Center (CFCCC) and California State University, Fullerton (CSUF) have established a collaborative partnership focused on addressing cancer disparities of the highest need in Orange County.
Dec 21, 2021
Virus-based sensor detects bladder cancer markers in urine
Researchers have made a virus-based biosensor that detects markers of bladder cancer in urine. Their goal is to make a dipstick that can quickly detect bladder cancer as part of routine urinalysis.